MRPs Category | Type of MRP | n (%) a | Example |
---|---|---|---|
Indication | Needs additional drug therapy | 236 (73.1) | Patient is asthmatic, but is not getting the recommended drug i.e. salbutamol puff PRN |
Unnecessary drug therapy | 38 (11.8) | Patient is on ceftriaxone 1 g IV BID but there is no indication of infection in the diagnosis | |
Effectivenes | Dosage too low | 38 (11.8) | Cephalexin 500 mg once PO daily given to patient to treat infection, PO BID daily is recommended |
Ineffective drug product | 12 (3.7) | HIV/AIDS (immunocompromised) and MRSA infected patient who was on wound care was on metronidazole and cephalexin treatment (less effective), instead patient was put on more effective drug, vancomycin 500 mg IV BID for 10 days | |
Safety | Dosage too high | 12 (3.7) | Patient is on ceftriaxone 2 g IV bid to treat chorioamnionitis which is high dose, 1 g IV BID is enough |
Adverse drug reaction | 2 (0.6) | Patient received furosemide and gentamicin concurrently. One increases toxicity of the other by pharmacodynamic synergism; alternative drug chlorothiazide was used in place of furosemide | |
Compliance | Non-compliance | 12 (3.7) | Anti-D immunoglobulin is available in the hospital, but the patient couldn’t afford and was not injected |
Other categories | Need for an additional laboratory test | 41 (12.7) | Patient haematocrit value is not registered to recommend or not iron supplementation or treatment |
Incomplete drug order | 3 (0.9) | Patient is prescribed with methyldopa 250 mg (mild pre-eclampsia), but duration was not indicated | |
Total MRPs | Â | 394 (100.0) | Â |